6-31878959-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025257.3(SLC44A4):c.22G>A(p.Glu8Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_025257.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC44A4 | NM_025257.3 | c.22G>A | p.Glu8Lys | missense_variant | 1/21 | ENST00000229729.11 | |
EHMT2-AS1 | NR_174947.1 | n.271+881C>T | intron_variant, non_coding_transcript_variant | ||||
SLC44A4 | NM_001178044.2 | c.22G>A | p.Glu8Lys | missense_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC44A4 | ENST00000229729.11 | c.22G>A | p.Glu8Lys | missense_variant | 1/21 | 1 | NM_025257.3 | P1 | |
EHMT2-AS1 | ENST00000642849.1 | n.271+881C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000797 AC: 20AN: 250804Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135612
GnomAD4 exome AF: 0.000113 AC: 165AN: 1461580Hom.: 0 Cov.: 32 AF XY: 0.0000866 AC XY: 63AN XY: 727096
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 22, 2024 | Variant summary: SLC44A4 c.22G>A (p.Glu8Lys) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-05 in 250804 control chromosomes, including 20 heterozygotes. To our knowledge, no occurrence of c.22G>A in individuals affected with Hearing Loss, Autosomal Dominant 72 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1368898). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1368898). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 8 of the SLC44A4 protein (p.Glu8Lys). This variant is present in population databases (rs374954632, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SLC44A4-related conditions. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at